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Tumor necrosis factor-a in combination with 
intederon-"i, but not with interleukin 4 activates 
murine macrophages for elimination of 
Leishmania major amastigotes* 
We have previously shown that du ring an infection with Leishmania major, 
susceptible BALB/c mice, as opposed to mice of a resistant strain (C57BLl6), are 
primed by lipopolysaccharide for the production of high levels of tumor necrosis 
factor-a (TNF-a) which is known to be a potent maerophage (Met» stimulator in 
other parasitic diseases. In the present study we investigated whether TNF-a 
activates Met> for kil11ing of L. major parasites. In the absence of interferon-y 
(IFN-y) or lipopolysaccharide, TNF-a (0.025-25000 U/ml) failed to activate 
peritoneal exudate Met> from BALB/c mice for killling of L. major amastigotes. 
In the presence of suboptimal doses of IFN-y (5 or 10 Vlml), however, TNF-a 
mediated a rapid elimination of intracellular parasites, which was highly 
significant compared to IFN-y alone. Tbe combination ofTNF with interleukin 4, 
in contrast, was inactive in this respect and allowed survival of intracellular 
parasites. From these data we conelude that the presence of IFN-y is crucial for 
TNF-a-mediated killing of L. major parasites by Met>. Disease progression in 
susceptible mice therefore seems to be a consequence of a deficiency of IFN-y and 
a predominance of interleukin 4 rather than the result of an excess amount of 
TNF-a. 
1 Introduction 
Leishmania are protozoan parasites which, in their amas-
tigote form (AM), muItiply within the phagolysosomes of 
non-activated Met> [1]. Tbe intracellular survival of AM is 
prevented when the Met> are stimulated by T cell-derived 
lymphokines [2]. It has been shown that IFN-y is the most 
important component among these Met>-activating media-
tors [3, 4], although other cytokines have also been 
implicated in anti-parasitic effects [5-9]. The role of IFN-y 
as the predominant lymphokine responsible for the ulti-
mate elimination of Leishmania from M$ is further 
ilIustrated by tbe fact that a Leishmania major infection in 
resistant C57BLl6 healer mice is associated with the 
expansion of IFN-y-producing CD4+ T lymphocytes, 
whereas in susceptible BALB/e mice, which finally succumb 
to the disease, IL 4-secreting CD4+ T lymphocytes prevail 
[101· 
Recently, we have demonstrated that mice infected with L. 
major are primed for the production of TNF-a in vivo (H. 
Moll, K. Binöder, C. Bogdan,W. Solbacb and M. Rölling-
boff, Parasite lmmunol., in press). We also found tbat 
during tbe course of an L. major infection, susceptible 
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BALB/c mice elicit a significantly higber LPS-induced 
TNF-a response than resistant C57BL/6 mice. In otber 
experimental systems the production of TNF-a has been 
associated with either protection [11-141 or damage of the 
bost organism [15-17]. These results together witb a 
number of reports on the capacity ofTNF-a to activate Met> 
for parasite elimination [18-21] prompted us to evaluate 
the effect of TNF-a on L. major-infected Met> in vitra. In 
the studies to be presented we demonstrate that TNF-a 
alone failed to activate murine M$ for killing of L. major 
amastigotes. However, in tbe presence of very low, subop-
timal dosages of IFN-y (5 or 10 V/mi) TNF-a induced rapid 
parasite degradation by tbe M$. In contrast, TNF-a in 
combination witb IL 4 supported intracellular parasite 
survival. The implications of these findings for the patho-
genesis of murine L. major infections will be discussed. 
2 Materials and methods 
2.1 Mice and parasite 
Female BALB/c mice, weigbing 16-18 g, were purcbased 
from Charles River Breeding Laboratories (Sulsfeld, FRG) 
and were used at tbe age of 6-8 weeks. The origin and 
propagation of the L. major strain used as weil as the in 
vitro culture of promastigotes was reported in detail 
previously [22]. AM suspensions were prepared from skin 
lesions of BALB/c mice 2-3 weeks after inoculation of 2 x 
107 promastigotes as described [23]. Briefly, infected tissue 
was disrupted and bomogenized by passage tbrough a 
stainless steel mesh into culture medium. AM were re-
leased from Met> by two vigorous passages of the primary 
cell suspension tbrougb a 27-gauge needle. Cell debris was 
removed by two steps of centrifugation at 120 x g (10 min), 
before the AM were recovered (1800 x g, 10 min) and 
washed twice. 
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2.2 Preparation 01 M4» c:ultures 
T cell-free M<I> monolayers were prepared and tested for 
purity as described in detail elsewbere [23]. Briefly, thlo-
glycolate-induced pe~toneal exudate cells we~e wasbed 
twice resuspended ID C-RPMI culture medIum 1640 
(Biochrom Berlin, FRG; supplemented witb 2 mM L-glutamin~, 10 mM Hepes buffer, 7.5% NaHC03, 
0.05 mM 2-MB, 100 "glmI penicillin, 160 "g/ml gentamycin 
and 10% selected FCS witb a total LPS content < 0.6 
nglml), seeded into Labtek tissue culture c~ambers (2 x 
IOS/cbamber; Flow Laboratories, Meckenbelm, FRG) and 
were alIowed to adbere for 3-4 b (at 37°C, 5% C02, 95% 
air bumidity); tbereafter, nonadberent cells were removed 
by tbree extensive washings ~ith ~Iture mediu~. Furth~r 
incubation was performed elther ID culture medIUm or 10 
culture medium witb various cytokines as indicated in the 
text. 
2.3 Cytokines and LPS 
Murlne rTNF-a [sp. act. 2.5 x 107 U/mg as determined by 
the supplier in a bioassay with murine tumor cells; LPS 
content of < 0.025 nglml as determined in the limulus 
amebocyte Iysate (LAL) assay] and murine rIFN-y [sp. act. 
1 x 107-2 X 107 U/mg as determined by the supplier in a 
bioassay witb mouse L cells; LPS content (LAL assay) 
0.0125 nglmI] were kindly provided by Dr. G. R. Adolf 
(Emst-Boebringer-Institut, Vienna, Austria). Murine rIL 4 
[biological activity: 1.4 x lOS V/mi, 1 V/mi gives balf 
maximum stimulation of cells of tbe HT-2 cellline; LPS 
contents (LAL assay): 0.5-5 ng/mI] was a gift from Dr. R. 
Coffman (DNAX Researcb Institute, Palo Alto, CA]. LPS 
(E. eoli serotype 055: B5) was purchased from Difco 
(Detroit, MI). 
2.4 M<I> stimulation with cytokines. infection 01 M4» 
and assessment 01 intraceUular parasit es 
Prior to infection, M<I> monolayers were incubated over-
night eitber in culture medium alone or in culture medium 
with LPS or cytokine(s). Tbe M<I> were tben infected witb 
AM (parasite: cell ratio = 5: 1) for 3 h in tbe respective 
medium. Tbereafter, non-pbagocytosed parasites were 
wasbed off, and the cultures were furtber incubated in the 
respective medium, wbich was replaced every 24 h. Intra-
ceUular live amastigotes were assessed as described in detail 
elsewhere [24]. Briefly, infected M<I> monolayers were 
incubated with a solution of acridine orange (5 "glml) and 
ethldium bromide (50 lAS/mI) in PBS for 10 min. After two 
washlngs the stained monolayers were fixed witb parafor-
maldebyde (1% in PBS) and evaluated witb a fluorescence 
microscope (450 nm-490 nm). Tbe percentage of infected 
M<I> (infection rate) and tbe number of parasitesl100 
infected M<I> (mean ± SEM of four observations on two 
cultures; 300-400 M<I> observed) were determined. From 
these values tbe mean number of parasitesl100 M<I> of the 
culture (= [infection rate: 100] x mean number of para-
sitesll00 infected M<I» was calculated. 
2.5 Presentation of results and statistical aualysis 
Tbe results in tbe figures and tables are expressed as mean 
± SEM. Differences between treated and control M<I> 
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cultures were tested for statistical significance by Student's 
t-test for unpaired sampies (two tailed). 
3 Results aud discussiou 
3.1 TNF-a alone fails to activate M4» for elimination of 
L. ftUljor AM 
In a first set of experiments, we analyzed tbe effect of 
murine rTNF-a on the infection of adherent peritoneal M<I> 
cultures with L. major AM. Pilot experiments showed tbat 
TNF-a alone did not promote the elimination of intracel-
lular AM at any ofthe dosages used (25000, 2500, 250, 25, 
2.5,0.25,0.025 V/mi). Although the M<I> monolayers were 
incubated witb medium containing TNF-a prior to and 
tbroughout tbe infection, we never observed a significant 
reduction of the initial infection rate or of tbe parasite 
number/lOO infected M<I> as compared to the medium 
control at any of the time points after infection (3, 24, 48, 
72, 96 h; data not shown). In 5 out 12 experiments 
treatment of M<I> with TNF-a even caused an increased 
parasite burden of the M<I> cultures after 48 and 72 h, the 
reason for which remains unknown so far. From these data 
we conelude that TNF-a lacks tbe capacity to activate M<I> 
for killing of L. major AM in the absence of co-stimulatory 
signals. Tbis result is in good accordance with earlier studies 
using Trypanosoma cruzi trypomastigotes for infection of 
residentperitoneal McIl [20], in whlch TNF-a alone was also 
found to be ineffective. On the other hand, Bermudez and 
Young [21] found that TNF-a increased the killing of 
Myeobacterium avium by human monocyte-derived McIl. 
Also, De Titto et al. [18] reported that TNF-a inhibits tbe 
multiplication of T. cruzi trypomastigotes in murine M<I>, 
wbereas the intracellular replication of Toxoplasma gondii 
tachyzoites or bradyzoites is not affected by TNF-a. Tbe 
effect of TNF-a therefore appears to depend on botb the 
infecting organism and the source of M<I> used. 
3.2 TNF-a induces parasite elimination in the presence 
of suboptimal dosages of IFN-y 
In other in vitro infection experiments it has been shown 
tbat TNF-a enhances M<I> destruction of intracellular 
pathogens in the presence of IFN-y [19] or LPS [20]. We 
tberefore investigated whetber TNF acts synergistically 
with a suboptimal dose of IFN-y (5 or 10 V/mI) or LPS (10 
nglmI) to induce M<I> killing of L. major AM. As demon-
strated in Fig. 1, in the presence ofIFN-y (Fig. 1 a) or LPS 
(Fig. 1 b) the stimulation of M<I> monolayers witb TNF-a 
(2500 Ulml) prior to and throughout the infection witb AM 
led to a hlghly significant reduction of the parasite load as 
compared to tbe medium control. This was due to a 
decrease of botb the infection rate and the average number 
of parasites per infected M<I> (data not shown). LPS or each 
of the cytokines alone were totally inactive in this respect 
(Fig. 1). 
Tbe synergistic anti-parasitic effect of TNF-a and IFN-y 
was dependent on the concentration of TNF-a. Vsing 5 
O/ml IFN-y, the lowest effective dose of TNF-a was 2.5 
Vlml (Thble 1). 
Higher dosages of IFN-y (20 or 100 UlmI) promoted 
parasite elimination without any co-stimulation; however, 
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Table 1. Effect of TNF-a on the elimination of AM by M$ in the presence of a constant dose of IFN-y·) 
IFN-y TNF-a Medium Hours 
after 
infection 
IFN-y (5 U/mI) 
+ 
TNF-a (U1ml) (U/mI) (U/mI) 
2SO 25 2.5 0.25 5 2S()b) 
3 
24 
48 
72 
602 
(± 39) 
910 
(± 63) 
281· 
(± 19) 
180· 
(± 13) 
611 
(± 42) 
941 
(± 46) 
342· 
(± 29) 
288· 
(± 16) 
576 
(± 41) 
86S 
(± 55) 
403· 
(± 14) 
308· 
(± 17) 
561 
(± 27) 
902 
(± 43) 
701 
(± 26) 
644 
(± 24) 
561 
(± 24) 
855 
(± 44) 
751 
(± 32) 
699 
(± 49) 
62S 
(± 36) 
930 
(± 51) 
769 
(± 33) 
780 
(± 41) 
580 
(± 22) 
865 
(± 37) 
758 
(± 22) 
735 
(± 51) 
a) Adherent M$ monolayers (2 x lOS/cham-
ber) were infected with a 5-fold excess of 
AM for 3 hand stimulated with 5 V/mi 
IFN-y and various concentrations of 
TNF-a throughout the culture period. 
Control cultures were set up witb eacb of 
the cytoldnes alone or in medium. Tbe 
numbers indicate the mean number of 
parasitesllOO Moll (± SEM) which was 
determined as described in the legend to 
Fig.1. 
b) Tbe results obtained witb 25,2.5 or 0.25 V/mi TNF-a alone were not statistically different and were therefore omitted in the table for 
the sake of brevity. 
'" Significantly different from controls witb TNF-a alone (p <0.(1). 
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Figure 1. Effect of TNF-a on tbe elimination of AM by Moll in the 
presence of IFN-y or LPS. Adberent Moll monolayers (2 x 
IOS/chamber) were infected witb a 5-fold excess of AM for 3 hand 
stimulated with TNF-a (2500 V/mI; .) throughout tbe culture 
period in tbe presence of (a) IFN-y (5 or 10 V/mi; e) or (b) LPS (10 
nglml; e). Control cultures were stimulated witb equal concentra-
tions of either TNF-a or IFN-y (0) or LPS (0) or were set up in 
medium alone (0). At tbe time points indicated the mean number 
of parasitesll00 Moll (± SEM) was determined as described in Sect. 
2.5. For tbe sake of clarity the results for tbe cultures witb 5 V/mi 
IFN-y are omitted, as they did not differ from those of cultures 
stimulated witb 10 V/mI IFN-y. • Significant as compared to all 
controls (p < 0.(1); •• highly significant as compared to 811 controls 
(p <0.(01). 
TNF-a (2500 Ulml) still enhanced the effect of IFN-y in a 
significant manner (Thble 2). Tbe synergistic anti-parasitic 
effect of TNF-a and IFN-y was not caused by LPS 
contamination in either of the cytokine preparation, 
because the LPS concentrations in the stock preparations of 
the cytokines « 0.025 nglml) were inactive and even lower 
than those in the culture medium itself « 0.6 ng/ml). The 
observed anti-parasitic action of TNF-a and IFN-y corre-
Iates with the finding that TNF-a and INF-y synergistically 
stimulate Mctl for the production of reactive oxygen and 
nitrogen intermediates [25], which are involved in the 
killingprocess of L. majorparasites [4, 26]. It is conceivable 
that the synergism is based on the well-established capacity 
of IFN-y to induce the expression of TNF-a receptors 
[27-29], whicb are also found on MCI» [30]. 
3.3 Co-stimulation 01 M4J) with TNF-a and IL 4 does 
not eause elimination 01 intraceUular parasites 
n... 4 appears to be associated with the progression of tbe 
disease in murine L. majorinfections [10, 31]. On the other 
hand, Mctl-activating and resistance-mediating functions of 
n... 4 have also been reported [9, 32,33], which prompted us 
to investigate the function of n... 4 in combination with 
TNF-a. When Mctl monolayers were incubated with 
medium containing n... 4 alone (280, 28 or 2.8 U/m1) prior to 
and throughout the infection with AM, we could neither 
observe a significant reduction nor an increase of tbe 
parasite burden of the Met> (data not shown). IL 4 (280, 28, 
2.8 U/mI) in combination with TNF-a (2500 U/ml) did not 
induce kiIling of L. major AM, but rather enhanced the 
survival of intracellular parasites as compared to IL 4 or 
TNF-a alone or the medium control (Fig. 2). These results 
iIIustrate that TNF-a in combination with IL 4 fails to exert 
a parasite-eliminating effect. 
4 Concluding remarks 
Tbe study presented here provides the first evidence that 
TNF-a in combination with suboptimal dosages of IFN-y 
induces killing of L. major AM by MCI». TNF-a alone or in 
1134 C. Bogdan, H. Moll, W. Solbach and M. Röllinghoff Eur. J. ImmunoJ. 1990.20: 1131-1135 
Table 2. Effect of INF-y on the elimination of AM by M<ll in the presence of a constant dose of TNF-aa) 
Hours IFN-y (V/mi) TNF-a (2500 Ulml) TNF-a (V/mi) Medium 
after + 
infection IFN-y (Ulml) 
5 20 100 5 20 100 2500 
3 412 400 316 395 471 407 318 325 
(± 38) (± 31 (± 25) (± 17) (± 20) (± 21) (± 28) (± 24) 
24 592 639 485 518 588 535 ~7 644 
(± 43) (± 42) (± 19) (± 22) (± 27) (± 33) (± 39) (± 37) 
48 603 614 499 376* 147* 117* 703 627 
(± 37) (± 35) (± 27) (± 17) (± 8) (± 10) (± 33) (± 41) 
72 581 157 123 30* si 0 588 480 
(± 21) (± 7) (± 9) (± 2) (± 29) (± 34) 
a) Adherent M<ll monolayers (2 x lOSIchamber) were infected with a 5-fold excess of AM for 3 hand stimulated with 2500 Ulml TNF-a 
and various concentrations of IFN-y throughout the culture period. Control cultures were set up with TNF-a or INF-y alone or in 
medium. Tbe numbers indicate the mean number of parasitesll00 M<ll (± SEM) which was determined as described in the legend to 
Fig.1. 
* See Fig. 1. 
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Figure 2. Effect of TNF-a on the elimination of AM by M<ll in the 
presence of IL 4. Adherent M<ll monolayers (2 x IOS/chamber) 
were infected with a 5-fold excess of AM for 3 hand stimulated 
with TNF-a (2500 V/mi; .) and IL 4 (28 Vlml; .) throughout the 
culture period. Control cultures received either TNF-a (.) or IL 4 
(0) or were set up in medium alone (0). Tbe cultures were 
evaluated as described in the legend to Fig. 1. * Significant as 
compared to medium and IL 4 alone (p < 0.01). 
combination with IL 4 was inactive in this respect. These 
findings have important implications for the understanding 
of the role ofTNF-a in the pathogenesis of murine L. major 
infections. Recently, it has been demonstrated that in 
murine L. major infections resistance correlates with the 
expansion of IFN-y-secreting CD4 + T Iymphocytes, where-
as disease susceptibility is associated with an increased 
number of IL 4-producing CD4 + T Iymphocytes and a lack 
of IFN-y-producing CD4+ T Iymphocytes [10]. On the 
other hand, a much higher LPS-induced TNF-a response is 
elicited in L. major-infected susceptible BALB/c mice than 
in resistant C57BLl6 mice (H. Moll et al. , Parasite Immu-
nol., in press), which most Iikely is the consequence of an 
increased proportion of M«I> in their lymphoid organs 
throughout the infection [34]. In the light of our present 
results, TNF-a is unlikely to activate M«I> for the elimina-
tion of parasites in L. major-infected susceptible BALB/e 
mice, because they fail to provide sufficient amounts of 
IFN-y as a eo-stimulatory signal as opposed to what occurs 
in resistant C57BLl6 mice ([10]; H. Moll et al., manuscript 
submitted). TNF-a per se does not appear to be a disease-
promoting Iymphokine. However, in the absence of IFN-y 
and the presence of IL 4, TNF-a may promote parasite 
survival. This process eould even be enhanced by granulo-
cyte-monoeyte CSF, which is known to be induced by 
TNF-a [35, 36] and causes expansion of non-activated 
M«I>/monocytes serving as "safe targets" for Leishmania 
parasites [34, 37]. In summary, our results represent a 
further example of functional synergism of TNF-a and 
IFN-y [19, 38-40], which may be of general relevance for 
the protection against intracellular parasites. 
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